Literature DB >> 13130130

The GW182 protein colocalizes with mRNA degradation associated proteins hDcp1 and hLSm4 in cytoplasmic GW bodies.

Theophany Eystathioy, Andrew Jakymiw, Edward K L Chan, Bertrand Séraphin, Nicolas Cougot, Marvin J Fritzler.   

Abstract

A novel cytoplasmic compartment referred to as GW bodies (GWBs) was initially identified using antibodies specific to a 182-kD protein termed GW182. GW182 was characterized by multiple glycine(G)-tryptophan(W) repeats and an RNA recognition motif (RRM) that bound a subset of HeLa cell messenger RNAs (mRNAs). The function of GWBs was not known; however, more recent evidence suggested similarities between GWBs and cytoplasmic structures that contain hLSm proteins and hDcp1, the human homolog to a yeast decapping enzyme subunit. In this study, we used antibodies to hLSm4 and hDcp1 to show that both of these markers of an mRNA degradation pathway colocalize to the same structures as GW182. Our studies demonstrate that GW182, hLSm4, and hDcp1 are found in the same cytoplasmic structures and suggest that GW182 is involved in the same mRNA processing pathway as hLSm4 and hDcp1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13130130      PMCID: PMC1370480          DOI: 10.1261/rna.5810203

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  24 in total

1.  A doughnut-shaped heteromer of human Sm-like proteins binds to the 3'-end of U6 snRNA, thereby facilitating U4/U6 duplex formation in vitro.

Authors:  T Achsel; H Brahms; B Kastner; A Bachi; M Wilm; R Lührmann
Journal:  EMBO J       Date:  1999-10-15       Impact factor: 11.598

2.  Plasma membrane compartmentalization in yeast by messenger RNA transport and a septin diffusion barrier.

Authors:  P A Takizawa; J L DeRisi; J E Wilhelm; R D Vale
Journal:  Science       Date:  2000-10-13       Impact factor: 47.728

3.  Targeting an mRNA for decapping: displacement of translation factors and association of the Lsm1p-7p complex on deadenylated yeast mRNAs.

Authors:  S Tharun; R Parker
Journal:  Mol Cell       Date:  2001-11       Impact factor: 17.970

Review 4.  Curbing the nonsense: the activation and regulation of mRNA surveillance.

Authors:  C J Wilusz; W Wang; S W Peltz
Journal:  Genes Dev       Date:  2001-11-01       Impact factor: 11.361

5.  Yeast mRNA decapping enzyme.

Authors:  T Dunckley; R Parker
Journal:  Methods Enzymol       Date:  2001       Impact factor: 1.600

6.  A novel mRNA-decapping activity in HeLa cytoplasmic extracts is regulated by AU-rich elements.

Authors:  M Gao; C J Wilusz; S W Peltz; J Wilusz
Journal:  EMBO J       Date:  2001-03-01       Impact factor: 11.598

7.  A Sm-like protein complex that participates in mRNA degradation.

Authors:  E Bouveret; G Rigaut; A Shevchenko; M Wilm; B Séraphin
Journal:  EMBO J       Date:  2000-04-03       Impact factor: 11.598

8.  Stress-induced nuclear bodies are sites of accumulation of pre-mRNA processing factors.

Authors:  M Denegri; I Chiodi; M Corioni; F Cobianchi; S Riva; G Biamonti
Journal:  Mol Biol Cell       Date:  2001-11       Impact factor: 4.138

9.  A phosphorylated cytoplasmic autoantigen, GW182, associates with a unique population of human mRNAs within novel cytoplasmic speckles.

Authors:  Theophany Eystathioy; Edward K L Chan; Scott A Tenenbaum; Jack D Keene; Kevin Griffith; Marvin J Fritzler
Journal:  Mol Biol Cell       Date:  2002-04       Impact factor: 4.138

10.  Autoantibody to hLSm4 and the heptameric LSm complex in anti-Sm sera.

Authors:  Theophany Eystathioy; Carol L Peebles; John C Hamel; John H Vaughn; Edward K L Chan
Journal:  Arthritis Rheum       Date:  2002-03
View more
  132 in total

1.  The decapping activator HPat a novel factor co-purifying with GW182 from Drosophila cells.

Authors:  Elisabeth Jäger; Silke Dorner
Journal:  RNA Biol       Date:  2010-05-14       Impact factor: 4.652

2.  RNA-binding protein L1TD1 interacts with LIN28 via RNA and is required for human embryonic stem cell self-renewal and cancer cell proliferation.

Authors:  Elisa Närvä; Nelly Rahkonen; Maheswara Reddy Emani; Riikka Lund; Juha-Pekka Pursiheimo; Juuso Nästi; Reija Autio; Omid Rasool; Konstantin Denessiouk; Harri Lähdesmäki; Anjana Rao; Riitta Lahesmaa
Journal:  Stem Cells       Date:  2012-03       Impact factor: 6.277

Review 3.  Posttranscriptional regulation of cancer traits by HuR.

Authors:  Kotb Abdelmohsen; Myriam Gorospe
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-05-06       Impact factor: 9.957

Review 4.  General principals of miRNA biogenesis and regulation in the brain.

Authors:  Dónal O'Carroll; Anne Schaefer
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

Review 5.  P-bodies and stress granules: possible roles in the control of translation and mRNA degradation.

Authors:  Carolyn J Decker; Roy Parker
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-09-01       Impact factor: 10.005

6.  A role for the P-body component GW182 in microRNA function.

Authors:  Jidong Liu; Fabiola V Rivas; James Wohlschlegel; John R Yates; Roy Parker; Gregory J Hannon
Journal:  Nat Cell Biol       Date:  2005-11-13       Impact factor: 28.824

7.  Decay of mRNAs targeted by RISC requires XRN1, the Ski complex, and the exosome.

Authors:  Tamas I Orban; Elisa Izaurralde
Journal:  RNA       Date:  2005-02-09       Impact factor: 4.942

8.  Clinical and serological associations of autoantibodies to GW bodies and a novel cytoplasmic autoantigen GW182.

Authors:  Theophany Eystathioy; Edward K L Chan; Ken Takeuchi; Michael Mahler; LeeAnne M Luft; Douglas W Zochodne; Marvin J Fritzler
Journal:  J Mol Med (Berl)       Date:  2003-11-04       Impact factor: 4.599

9.  Inhibition of Axon Regeneration by Liquid-like TIAR-2 Granules.

Authors:  Matthew G Andrusiak; Panid Sharifnia; Xiaohui Lyu; Zhiping Wang; Andrea M Dickey; Zilu Wu; Andrew D Chisholm; Yishi Jin
Journal:  Neuron       Date:  2019-08-01       Impact factor: 17.173

Review 10.  Deadenylation and P-bodies.

Authors:  Chyi-Ying A Chen; Ann-Bin Shyu
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.